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Ever increasing numbers of immune mechanisms and types
of nephritogenic antigen-antibody systems are being identified
in model systems of immune injury in the renal tubulointerstitial
tissues (Table 1). Some of these nephritogenic model systems
are also suspected or established in subsets of human immune
tubulointerstitial nephritis (TIN) [1, 2]. The nephritogenic im-
mune mechanisms include direct antibody reactions with struc-
tural or cell surface antigens and non-native antigens either
trapped in the kidney or available for reaction in the circulation
to form immune complexes. Cellular immune reactions play
varying and sometimes dominant roles as well and may involve
antigen systems similar to those of the antibody dominated
lesions.
When antibodies react with structural antigens, an immune
deposit is typically formed. The injury produced by these
immune deposit-related antibody reactions is usually generated
by subsequent cellular and humoral mediator activation, which
may include the production of factors such as cytokines and
growth factors from renal cells themselves.
The nephritogenic antigens may also be elements of the renal
tubular cell surface. In addition to forming immune deposits,
antibody reactions with these cell surface elements may lead to
selective damage to the individual renal tubular cells. Glomer-
ular examples of selective antibody-induced epithelial and
mesangial cell damage, which can include frank lysis in the case
of the mesangial cell, occur with the assistance of mediator
molecules, that is, the terminal complement cascade generating
the membrane attack complex (MAC).
In addition, antigens not native to the site, including drugs or
their metabolites and products of infectious agents, may be-
come trapped or replicated in the tubulointerstitial renal tissue,
potentially becoming targets for antibody attack involving ei-
ther immune deposit formation or cell surface types of injury.
For example, drugs or their metabolic products can combine
with renal structures and serve as targets for nephritogenic
antibody reactions, or function as haptens with the potential of
generating immune responses directed toward the native renal
structure that serves as the carrier molecule in a hapten/carrier
complex.
Tubulointerstitial immune deposits can also form via immune
complex mechanisms in which antigens not native to the kidney
are complexed with antibody in the circulation or in situ at the
site of a deposit. Since the antigen in this type of reaction is
soluble and therefore free to move away from the site during
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dynamic interchange, these immune complex deposits are usu-
ally changing in composition relative to the antigen or antibody
ratio in the adjacent body fluids.
Drugs or toxins such as mercuric chloride, in addition to
damaging renal tubules, can also serve as polyclonal B cell
stimulants associated with a variety of autoimmune reactions,
including some with anti-renal effects [3]. Molecular mimicry of
antigenic epitopes between autologous antigens and foreign
(often infectious agent associated) antigens can lead to forma-
tion of cross reactive antibodies which could be nephritogenic.
Genetic variation in antigen content within renal structures
such as the renal basement membranes can also lead to induc-
tion of humoral (and cellular) immune responses when intro-
duced, for example, in the form of renal transplants.
The identification of antigens involved in cellular immune
reactions as inducers of injury in the kidney lags behind that of
antigens in nephritogenic antibody reactions. A role for cellular
immune reactions can be shown in models, and the contribution
of this arm of the immune response is potentially very important
in many forms of TIN in humans, which are characterized by
mononuclear interstitial infiltrates usually dominated by T cells
with varying preponderance of T helper (CD4) and T suppres-
sor/cytotoxic (CD8) phenotypes [2, 4]. Such antigens would
be sought by their ability to react with sensitized T cells.
The antigens, as well as their location and physical state,
determine in large measure what type of immunopathogenic
process will develop (immune deposit, cell injury, etc.) in the
event of a nephritogenic humoral (or cellular) immune re-
sponse. For this reason, the identification of the nephritogenic
antigen provides a useful means of subdividing the various
forms of immunologically-induced TIN.
Antigens in predominantly humoral nephritogenic immune
reactions
Basement membrane related antigens
The antigenicity of the very distinctive glomerular basement
membranes (GBM) and the tubular basement membrane (TBM)
have long been studied in model systems [2] (Table 2). In
addition to actively induced models, spontaneous development
of anti-TBM antibodies has been described in the murine lupus
models and in a Samoyed dog [5, 6]. These basement membrane
structures have been shown to contain nephritogenic antigens
important in human renal disease as well [1, 2]. At least two
major types of anti-TBM antibody reactivity have been recog-
nized in model systems and in humans. In one type, antibodies
form which react with antigens in both the GBM and TBM.
Such reactions can be purposely induced by immunization of
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Table 1. Nephritogenic antigens in tubulointerstitial nephritis
Antigens involved in nephritogenic antibody reactions
Antigens within the kidney as targets of direct antibody reaction
Native renal elements including molecular mimicry
Non-native materials present in the kidney
Soluble antigens involved in immune complex accumulation
Antigens involved in nephritogenic cellular immune mechanisms
Antigens associated with delayed type hypersensitivity
Antigens in cellular forms of TIN:
Native renal elements, ? non-native materials
? Renal tubular antigens in renal tubular functional disorders
Table 2. Antigens in predominantly humoral nephritogenic immune
reactions
Nephritogenic antigens as targets of direct antibody reactions
Renal structural elements
Basement membrane antigens
TBM, GBM/TBM, ? including IBM-drug conjugates
Renal tubular cell products or surface antigens (native or ? non-
native)
brush border antigens, Tamm-Horsfall protein, ? drugs, ?
microbii antigens, ? other
Molecular mimicry and cross reactive antigens
Nephritogenic antigens involved in immune complex accumulation
Soluble exogenous or endogenous antigens
Serum proteins, drugs, products of infectious agents, tissue
components, etc.
Dynamic in situ reactions including trapped or planted antigens
DNA, idiotypic antigens, etc.
rats with GBM antigens [7, 81. In most instances, it is not
known if these anti-GBM/TBM antibodies react with one or
more epitopes of the numerous extracellular matrix compo-
nents that may be shared between the GBM and TBM or
whether multiple antibodies with different specificities are in-
volved. Systemic injection of these antibodies usually results in
binding largely confined to GBM sites. In the other type of
anti-basement membrane antibody reaction, antibodies form
with reactivity that appears to be directed only to the TBM. The
antibody is defined as anti-TBM because it reacts with antigens
distributed evenly in the region of the TBM; however, it is not
yet clear whether the antigen is a component of the TBM or a
substance closely associated with it. The reactive TBM antigen
expression is genetically variable in rats and humans.
Not all antibodies that can react with renal basement mem-
branes sites are necessarily nephritogenic, and additional fac-
tors such as the temporal and quantitative features of binding as
well as host response may play a role. For example, guinea pigs
immunized with bovine TBM develop antibodies reactive with
both the GBM and TBM; however, renal inflammation is
confined to the tubulointerstitial tissue [9, 101. Studies of the
two types of antibodies in this model suggest that the nephrito-
genic anti-TBM antibodies react with noncollagenous compo-
nents of the TBM in comparison to the non-injurious anti-GBM
antibodies which react with collagenous elements in the GBM
[11].
The nephritogenic TBM antigens may be confined to certain
segments of the tubule and as such would be expected to be
epitopes associated with basement membrane elements that
were important for the function of the particular tubular seg-
ment. For example, the basement membrane of the macula
densa is structurally distinct from the adjacent TBM [12].
Anti-TBM reactive antibodies often are found in patients with
anti-GBM antibody disease and Goodpasture's syndrome [13].
When present, the TBM reactive antibodies are of at least two
types: detecting antigenic sites that are distributed either dif-
fusely in the basement membrane region of most tubular
segments or very selectively in only certain tubular segments.
The presence of anti-TBM antibodies in these patients is
associated with a greater degree of tubulointerstitial inflamma-
tion [14]. In models of anti-TBM antibody disease in the guinea
pig or the rat, the reactive antigen present in the proximal
tubule's basement membrane ends abruptly at its junction with
Bowman's capsule..
Immunization (in adjuvants) with heterologous TBM antigens
can be used to induce nephritogenic autoimmune mechanisms
in which either antibody mechanisms or cellular immune pro-
cesses are dominant, depending on the species and strain of
experimental animal used [21. The reactive TBM antigens in
these models generally are confined to the proximal convoluted
tubule. Antigens from the murine EHS tumor can induce
anti-TBM antibodies and, in addition, generate anti-tubular
brush border antibodies similar to those seen in Heymann's
nephritis [151. The induction of anti-TBM antibody can be
modulated by pre-immunization using the antigen in incomplete
Freund's adjuvant, which increases suppressor cells [16]. The
immune response to autologous TBM immunogens in rats is
thought to be controlled by a cyclophosphamide-sensitive sup-
pressor cell mechanism [17]. The lesion is also modulated by
cyclosporin A treatment, which affects both humoral and cel-
lular elements of the immune response [18, 19]. In addition, the
anti-TBM antibody response can be modified by the action of
anti-idiotypic antibodies [20—23]. When rats are immunized with
TBM antigens, a suppressor cell appears shortly after immuni-
zation which interferes with the appearance of autologous
anti-idiotypic antibodies and limits regulation of the anti-TBM
antibody response [24].
Rats and guinea pigs have a large antibody component in their
anti-TBM antibody-associated TIN [9—11, 25, 26]. In contrast,
mice, particularly the susceptible SJL strain, have prominent
cellular immune elements in their more slowly developing TIN
lesion, with the concomitant anti-TBM antibody having a
largely unquantitated role [27—30]. Analysis of the murine
anti-TBM antibodies, whether from susceptible or nonsuscep-
tible strains, show no differences in quantity, epitope speci-
ficity, or idiotype [31]. Exposure to monoclonal anti-TBM
antibodies in vivo using anti-TBM antibody producing hybrid-
omas also did not produce TIN in mice [32, 33]. A murine
proximal tubular epithelial cell line has been developed which
secretes the putative TBM antigen termed 3M-i of 30,000 Mr
[34]. Anti-3M-i antibody causes injury only when transferred
into mice which preferentially develop Lyt-2 effector cells
[31].
In a recent study, transfer of 1gM monocional antibody
reactive with proximal tubule TBM induced low molecular
weight proteinuria within eight days in mice [35]. Fixation of the
antibody was observed along the TBM and focal infiltrates were
present. Electron dense deposits were observed in some areas
of the proximal tubule TBM. The reactive antigen responsible
Wilson: Nephritogenic tubulointerstitial antigens 503
was not defined, and the antibody was induced with homoge-
nized slices of Wistar rat renal cortex. The presence of electron
dense deposits suggests an antigen system different than the
typical anti-TBM disease in the mouse.
In the guinea pig, the TBM antigens can be targets for binding
of passively administered anti-TBM antibody with humoral (C3)
and cellular mediator activation in passive transfer experiments
[36—38]. The passive transfer of anti-TBM antibodies in the
guinea pig is capable of inducing an autologous anti-TBM
antibody response [39]. Transfer of human anti-TBM antibodies
to guinea pigs has been unsuccessful in inducing lesions [40].
The anti-TBM antibody disease of the BN rat can also be
induced by passive antibody transfer [25]. In the Brown Nor-
way rat, the kinetics of anti-TBM antibody binding have been
studied with paired label isotopic techniques and show gradual
fixation of antibody peaking five to six days after administra-
tion, suggesting that the reactive TBM antigen is relatively
sequestered from the circulation [41]. The amount of antibody
binding necessary to produce evidence of histologic injury by
passive transfer is about 170 /Lg/g of kidney. In comparison
about 75 g/g of nephritogenic anti-GBM antibody, which binds
maximally in minutes, induces glomerular injury also in a
matter of minutes. The binding of the anti-TBM antibodies
begins in focal cortical areas associated with C3 fixation and an
associated cellular inflammatory response. The binding be-
comes more widespread in the cortex with time and exposure to
increased amounts of antibody. Studies have not yet been done
to see if the relative sequestration of TBM antigens from
reaction with circulating anti-TBM antibodies can be altered, as
in the case of anti-lung basement membrane antibodies by
tissue reactions associated with 02 treatment, hydrocarbon
exposure, or cytokine infusion [42—45]. Elution studies had also
indicated the quantitative features of antibody binding neces-
sary for disease induction, with the susceptible BN strain
having the greatest amounts of renal bound antibody; some
differences in amount of reactive antigen also might be involved
[26].
The nephritogenic TBM antigens reactive with BN rat anti-
TBM antibodies are unavailable for antibody reaction in vivo or
on cut kidney section in vitro in the LEW rat [25, 26]. Of
interest, the LEW strain does develop a cellular form of TIN
when immunized with TBM antigen from the BN strain, and the
LEW does have an intact GBM/TBM antigen system reactive
with such antibodies from human serum [461. Occasional LEW
rats immunized to induce cellular immune TIN develop an
anti-GBM/TBM response similar to that in human anti-GBM
antibody disease. The similarity in antibody reactivity of the
LEW rat is sufficient to be detected in a radioimmunoassay
developed to detect the spontaneously-formed human anti-
TBM antibody. The absence of immunologically reactive anti-
gen in the native LEW TBM is incomplete since reactive TBM
antigens can be detected in solubilized fractions of LEW TBM
[47].
The allotypic differences in TBM antigens noted in the BN
and LEW rat strains can be used to induce anti-TBM antibodies
in transplantation studies. That is, if a TBM antigen positive
(TBM Ag) LEW x BN F1 kidney is placed in a TBM Ag
LEW recipient, anti-TBM antibodies will develop [48]. The role
of the antibody in long-term graft survival is difficult to separate
from that of rejection histopathologically [49]. Induction can
also occur by transfer of parenteral TBM Ag lymphocytes into
a TBM Ag F1 [50]. Transplacental transfer of anti-TBM
antibodies to F1 TBM Ag offspring occurred in female LEW
rats induced to develop such antibodies [51]. The nephritogenic
TBM antigen(s) appears to be inherited as a dominant gene
which does not segregate with the major histocompatibility
complex (MHC) of the rat (RT1) [52—54]. Studies suggest that
the TBM antigen is linked to genes for pinkeye dilution and
albinism on the first linkage group [55, 56]. More recently,
studies using monoclonal antibodies suggest that the TBM
epitope is linked to glycolate oxidase and map with the fourth
linkage group [57].
The genetic variations in TBM antigens observed in the LEW
rat is part of a larger picture in which nephritogenic GBM or
TBM antigens have been noted to be absent in some disease
situations. For example, the nephritogenic GBM antigen is not
available for antibody reaction in some kindreds of patients
with hereditary nephritis of the Alport's syndrome type and in
an apparent model counterpart in Samoyed dogs [58, 59]. The
TBM of patients with nephronophthisis is said to be inconsis-
tent in its staining reaction with human anti-TBM antibody,
suggesting an underlying genetic defect in its structure as well
[60]. Rarely, reactive TBM antigens have been noted to be
absent in humans [61]. In one instance, as in the LEW rat, the
genetic variation in TBM antigen led to induction of anti-TBM
antibody formation when transplantation of a TBM Ag kidney
into a TBM Ag patient was done.
The TBM is the major support for the tubular epithelial cells
and as such presumably is involved in some aspects of the
tubular cell function, interposed as it is between the tubular cell
and the peritubular capillary. The TBM is difficult to isolate in
an absolutely pure form, so that determination of its exact
composition is incomplete; it is known to contain several
components of extracellular matrix including type IV collagen,
laminin, entactin and heparan sulfate proteoglycan [62—66]. The
chemical composition of human TBM and changes in it related
to age have been studied [67, 68]. Reversible alterations in the
composition of TBM induced by feeding rats 2-amino-4,5-
diphenylthiazol are associated with development of cystic renal
disease [69—701. Molecular studies suggest decreased mRNA
for alpha-I (IV) chain of type IV collagen as well as laminin B I
and B2 in congenital murine polycystic disease [71, 72].
The TBM antigens of selective anti-TBM antibody disease
reside in the TBM region of the proximal renal tubule but are
generally absent from other renal and extrarenal basement
membrane regions studied, with the possible exception of the
small intestine. A number of attempts have been made to
identify and characterize the antigenic material present, and the
reactive epitopes reside on molecules of somewhat different
molecular weight in the various species studied. A 30 kD
material recovered from trypsin digests of murine or human
TBM was found to induce anti-TBM antibody responses and
TIN in goats and BALB/c mice in the absence of detected
anti-GBM antibody reactions [73—75]. As noted earlier, the
3M- 1 antigen from cultured murine proximal tubular cells is
about 30 kD and was identical in size to an immunoaffinity
purified antigenic fraction from collagenase-solubilized mouse
TBM [34]. The reactive antigen from BN rat TBM can be
solubilized using collagenase and using specific absorption
techniques, a moiety of approximately 42 to 45 kD (as deter-
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mined by SDS PAGE) was shown to account for about 70% of
the reactivity of eluted anti-TBM antibody that could be de-
tected using the total particulate BN TBM [471. A nephritogenic
TBM antigen of about 48 kD was recovered from collagenase
extracts of rabbit TBM using a monoclonal antibody, termed
3M-i, reactive with BN but not Lewis TBM [761. The antigen
was noted to be localized in the most lateral aspects of the TBM
adjacent to the interstitium. The putative nephritogenic TBM
antigen, termed 3M-i, and the target antigen in the human
counterpart are cross reactive moieties of about 48 kD; they
bear a dominant epitope recognized by monoclonal antibodies
generated by the BN rat [23]. The monoclonals cross-inhibit
human anti-TBM antibody reactivity with the human equivalent
of 3M-i. The ability of an anti-idiotype reactive with an epitope
shared by the monoclonal anti-TBM antibodies to suppress
disease and delayed type hypersensitivity when given with
immunization or later suggests that a single or limited number of
reactive epitopes may be involved in disease induction. A
monoclonal anti-TBM antibody (reactive with BN but not LEW
TBM) derived from a BN rat given mercuric chloride has been
used to detect a 48 kD protein in collagenase digested BN TBM
[57]. When compared to the 3m-i specific mouse monoclonal
antibody, different but closely associated epitopes on the same
48 kD moiety were found.
A tubular cell cDNA library has been screened with a
monospecific polyclonal 3M-i reactive anti-TBM antibody, and
a group of cDNA were isolated which, in aggregate, define the
3M-i antigen as a complex, novel structure containing five
distinct amino acid termini all sharing a common framework
domain [77]. Comparisons of the anti-TBM antibody binding
sequence suggest a 37% non-repetitive structural similarity with
some intermediate filament-associated proteins (Neilson, E.G.,
personal communication). The intermediate filament-associated
proteins constitute a rather large and heterogeneous protein
family that contributes to the organization of the intracellular
infrastructure, as well as provides specialized support for
cell-cell surface interactions at desmosomes, or with extracel-
lular matrix at basal hemidesmosomes [78]. Candidate peptide
fragments were deduced and synthesized from the sequence
encoding this common framework domain, and one of the
peptide residues was able to bind to a monoclonal 3M-i-
reactive anti-TBM antibody, stimulate the growth of 3M-i-
reactive helper T cells, as well as induce nephritogenic effector
T cells capable of producing TIN (Neilson, E.G, personal
communication). These findings indicate that a small and
unique, immunodominant region of the 3M-I antigen, once
evolutionarily related to the family of intermediate filament-
associated proteins, provides a sufficient recognition structure
for this model of TIN.
Studies in the early 1970's suggested that a 70 kD protein
derived from collagenase extracts of human TBM was reactive
with human anti-TBM antibodies, including those with concom-
itant anti-GBM reactivity [79]. More recently, monoclonal
antibodies reactive with rat TBM were used to recover reactive
antigens in collagenase extracts of human renal basement
membranes [801. A 48 kD material reactive with two human
anti-TBM antibodies, but not with anti-GBM antibody, was
found. In another study, 48 and 54 kD antigens were reported to
be reactive with anti-TBM antibodies with the 48 kD band
remaining after reduction [81]. A 58 kD material reactive with
anti-TBM antibodies was recovered using 6 M guanidine/HCL/
0.50 M TRIS with proteinase inhibitors [82]. The anti-TBM
antibodies used were not reactive with extracts of GBM. The 6
M guanidine solubilization was reported to be more effective in
releasing the reactive antigen than was collagenase, suggesting
some possible sequestration of the antigen as has been sug-
gested to occur with nephritogenic GBM antigens. It is not
currently known why the molecular weights of reactive antigens
vary with the different solubilization and/or purification steps,
although these may generate fragments of differing size contain-
ing the reactive epitope(s). The relationship of the reactive
antigen to structural proteins within or adjacent to the TBM
remains incompletely defined. It will be of interest to see if
there is any relationship between the structural derivation of the
TBM and GBM antigens. Both appear to be present in non-
collagenous portions of the renal basement membrane prepara-
tions remaining after collagenase digestion. The GBM antigen
has been suggested to be present in noncollagenous portions of
the globular NC 1 domain of type IV collagen perhaps related to
a new collagen chain [83—86].
TBM-drug conjugates and other drug or hapten antigens
The relationship between anti-TBM antibodies and the TIN
that can accompany drug toxicity, such as seen with methacillin
[87, 881, phenytoin [89], and possibly allopurinol [90], is of
interest. In the case of methacillin-associated TIN, circulating
and renal bound anti-TBM antibody were associated with the
dimethoxyphenylpenicilloyl (DPO) breakdown products of
methacillin. This observation suggested that the DPO might be
associated with the TBM, inducing a hapten carrier mechanism
in which the antibody was reactive with the TBM after being
induced by the hapten affixed to the TBM carrier [88]. A similar
mechanism was suggested in the case of phenytoin-associated
TIN in which anti-TBM antibodies were observed with pheny-
tom present along with TBM [89]. Since anti-TBM antibodies
are found only infrequently in drug-induced TIN, their occa-
sional identification provides an incomplete answer to under-
standing the pathogenesis of drug associated forms of tubular
interstitial injury, although they presumably contribute to the
inflammation when present [91, 921. The same drug-carrier
mechanism could be responsible for the induction of other
antibodies which could contribute to TIN. Immune deposits,
which are not common in drug-related human TIN, might be
expected in such a reaction; however, antibody effects capable
of altering cellular function or causing inflammation can occur
with difficult to detect levels of antibody binding.
Anti—TBM antibodies have been reported to develop in about
20 weeks in guinea pigs that have been given sodium aurothio-
malate [93]. The induced autoimmune reaction is complex since
antibody reactions were also noted with renal tubular antigens
prepared like the Heymann nephritis antigen, Fx1A. Sodium
aurothiomalate has been suggested to act as an inhibitor of
suppressor activity with the ability to induce TIN in the usually
resistant C57B1/6 mouse [94]. Nephrotoxic agents such as
mercuric chloride have also been noted to induce a variety of
autoimmune responses including antibodies reactive with the
GBM or TBM [3, 57, 951.
Purposeful immunization to cephalothin in mice followed by
intrarenal cephalothin-carrier complex injection produced tubu-
lar injury [96, 97]. Studies also were done suggesting an
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antibody mechanism by passively administering monoclonal
anti-hapten antibodies, followed by intrarenal hapten-carrier
conjugates injections.
Renal tubular cell products or surface antigens
The reaction of antibody with cell surface antigens may have
an effect much like that of reaction with other structural
antigens leading to immune deposit formation. In addition, the
antibody may react with and alter the cell sometimes leading to
its death. Examples in the glomerulus include the binding of
antibody to glomerular epithelial cell surface antigens in Hey-
mann's nephritis [98—102], and the lysis of mesangial cells using
antibodies reactive with Thy-i-like antigens on their surface
[103—107]. Thy-I has been identified in the proximal tubular
epithelium of human kidney [108]. Antigens being excreted by
the cell, such as thyroglobulin in experimental murine thyroidi-
tis [109], have the same potential, so that both cell surface and
excreted products would need to be considered in evaluating
tubular antigens in TIN.
Antibodies reactive with the proximal renal tubular brush
border as well as cytoplasmic antigens have been recovered
from eluates of kidneys with immune deposits adjacent to the
basal membrane of the renal tubular cell in rabbits as occurs
after immunization with homologous tubular antigen, human
tubular brush border antigens (Fx1A), or given repeated renal
transplants [110—1121. The peri-TBM location of the immune
deposit in the rabbit is reminiscent of the subepithelial glomer-
ular deposit in Heymann's nephritis in rats, in which there is
considerable evidence that a capping and shedding mechanism
of a glomerular epithelial cell surface antigen is occurring
[98—102]. The location of the deposits (between the TBM and
the basal membrane of the proximal tubular cell) in the rabbit
model of tubulointerstitial deposits would be compatible with a
similar mechanism, although the antigen on the basal aspect of
the cell has not been identified.
The proximal renal tubular brush border is the site of another
direct antibody reaction in some stages of Heymann's nephritis
(induced by immunization with crude renal tubular antigens,
Fx1A [113, 1141) in which the induced circulating anti-brush
border antibodies of this model can gain access to the tubular
fluid [115, 1161. The brush border may be stripped from the cell
surface. The brush border binding and evidence of proximal
tubular cell injury correlates with the onset of proteinuria at five
to seven weeks after immunization when antibody levels are
high [117]. Maneuvers designed to induce proteinuria allow
administered anti-brush border antibody to reach the tubular
fluid, resulting in brush border binding and tubular cell lysis
[118]. Although C3 deposits occur, studies using cobra venom
factor to deplete complement suggest that the cell damage is
complement independent, perhaps related only to the physical
effects of the antibody-related clumping and shedding of brush
border membrane fragments. It is not clear if all the brush
border antigen reacted with antibody is shed into the tubular
urine or if some is internalized and accounts for the cytoplasmic
and basal deposits of immunoglobulin that may be seen in some
stages of the lesion. The cytoplasmic deposits could form
through antibody reactions with other cellular antigens. Anti-
body binding is associated with increased tubular cell division
and divalent antibody binding is required, suggesting a cross
linking of antigenic determinants is involved in the stimulus
[119, 120]. The antibody reaction with the proximal tubular
brush border is associated with functional abnormalities [1211.
Tubular dysfunction can also be found in rats immunized with
basolateral membranes, which induce a Heymann's nephritis-
like picture with circulating antibody predominately reactive
with cytoplasmic antigens of the proximal and distal tubule
[1221.
The complex structure of the brush border area has recently
been reviewed and a number of possible antigens exist [123].
The Heymann's nephritis antigen, Fx1A, is a crude renal
antigen and antibodies reactive with it, particularly heterolo-
gous antibodies, have many different types of anti-kidney
reactivity including activity against laminin, fibronectin, type
IV collagen and dipeptidly peptidase IV [124, 125]. Other
antigens of the brush border include CD1O, hydrolases, cross-
reactive parathyroid antigens, renal tumor antigens, other lym-
phohemopoietic differentiation antigens, and a 28 kD protein
shared with erythrocyte membranes [l26—1361. Villin, vimentin,
and epithelial membrane antigen may be seen in differentiating
and damaged proximal tubules and may be useful as markers of
renal carcinoma; they could also be considered candidates for
possible nephritogenic immune reaction [137—1401.
The antigen(s) involved in the tubular injury associated with
anti-Fx1A antibodies have not been defined with certainty but
would be expected to include gp330, one of the major antigens
of Heymann's nephritis membranous glomerulopathy, which is
present in coated pits near the base of the brush border
projections and at the bases of the glomerular epithelial cell foot
processes [123, 141—143]. A 400 kD protein from the brush
border of human kidneys has been identified which is similar to
gp 330 [144, 145]. gp330 has regions of homology with human
low-density lipoprotein receptor [146]. Although studies show
reactivity of gp 330 with eluted antibody from kidneys of rats
with active Heymann's nephritis [147], additional antigen/anti-
body systems appear to contribute to the full blown lesion. A
number of monoclonal antibodies have been produced to com-
ponents of Fx1A or other tubular membrane components,
although their role in brush border injury is not determined
[148—152]. A 280 kD protein found in the coated pits of the renal
brush border is shared with the epithelial cells of the yolk sac
[153], and antibodies reactive with a 160 kD protein of the
proximal tubule brush border have been reported in mice with
chronic graft-versus-host disease [154]. A rather large number
of brush border surface components could serve as antigens for
reaction with antibody that gained access to the tubular urine.
The antigen density, mobility in the plasma membrane, and
relationship to intracellular signalling would all determine the
effect of an antibody reaction.
Anti-brush border antibodies are occasionally found in pa-
tients with TIN or after renal transplantation [l55L suggesting
that they might be involved in tubular injury by a similar
mechanism or by reaction with the luminal aspect of the
proximal tubular by entry into the tubular urine. Urinary brush
border antigens have been suggested as a marker of tubular
damage [156—158]. Anti-renal tubular brush border antibodies
have been reported in a patient with Fanconi syndrome and
TIN who had IgG and C3 deposits in the proximal tubule in
addition to glomerulonephritis [159]. In another patient with
TIN, oliguria, and peritubular Ig deposits, anti-brush border
antibodies were recovered in kidney eluates [160]. Antibodies
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reactive with renal homogenate supernatants were noted in the
urine of patients with urinary tract infection [161].
The Tamm-Horsfall protein associated with the tubular cells
in the ascending limb of the loop of Henle and in the distal
convoluted tubule [162—164] is another cellular antigen that can
be a target for antibody reactions much like the antigens of the
proximal tubule just discussed. The Tamm-Horsfall protein is
identical to a urinary glycoprotein called uromodulin, which can
bind a number of cytokines including IL-i and TNF [165]. The
role of the Tamm-Horsfall protein in inflammation may then be
complex. As in the case of the proximal tubular antigens,
antibody reactions with the Tamm-Horsfall protein have two
patterns or types of reactions. The first pattern is found in rats
or mice actively immunized with the Tamm-Horsfall protein in
which immune deposits containing the protein form near the
basal areas of the cells [166—168]. Deposits can also be induced
by passive administration of heterologous anti-Tamm-Horsfall
protein antibodies [169]. If the kidney from an actively immu-
nized rat is transplanted to remove it from continuing antibody
reaction, the basal deposits will disappear in about two weeks
[170]. Rabbits also develop TIN after immunization with the
Tamm-Horsfall protein; however, a cellular mechanism is sug-
gested since immune deposits are not a feature of the lesion in
spite of circulating anti-Tamm-Horsfall protein antibody and
sensitized peripheral lymphocytes are present [171, 1721. Uri-
nary obstruction in mice leads to interstitial deposits of Tamm-
Horsfall protein (adjacent to the distal convoluted tubule) which
are reactive with antibody if the mice are immunized with the
protein [173].
A second pattern of anti-Tamm-Horsfall protein reaction is
found in rats rendered proteinuric, allowing access of the
antibody to the tubular urine. In this situation the antibody can
bind to the surface of the cells of the ascending limb of the loop
of Henle [174]. The reaction is much like that described with
proximal tubular cell surface antigens when antibody reaches
the tubular urine and allows the study of cell surface changes in
the distal nephron.
The role of immune reactions to the Tamm-Horsfall protein in
human tubulointerstitial renal injury primarily or related to
obstruction or infection is being evaluated. The distribution of
the Tamm-Horsfall protein is altered by urinary obstruction in
model systems [175—177], and antibodies to it have been noted
in patients with urinary tract infection, often with reflux
nephropathy. The relationship of the antibody to inflammation
remains unclear [178, 179]. In rats, antibodies reactive with
renal tubular cells have been found in association with intra-
renal injection of bacterial endotoxin or retrograde pyelonephri-
tis [180, 181], and a cross reaction between the Tamm-Horsfall
protein and Escherichia co/i has been suggested [182]. 1gM
eluted from the kidney of a patient with glomerulonephritis
associated with obstructive uropathy had reactivity with tubu-
lar epithelium although the antigen was not defined [183].
Other renal tubular cell surface antigens, such as angiotensin
converting enzyme [184], may be targets for nephritogenic
antibody reactions. Passive administration of antibodies reac-
tive with the angiotensin converting enzyme produces deposits
of IgG and C3 in the basolateral compartment of the proximal
tubular cell [185]. This suggests that the antibody may pass
through the TBM from the peritubular capillary to reach this
cell surface enzyme. Maneuvers to alter glomerular permeabil-
ity allow the anti-angiotensin converting enzyme antibody to
enter the tubular urine and react with the brush border.
Monoclonal antibodies are being developed to identify dif-
ferent segments of the nephron as well as associated transport
proteins. For example, the distal tubule and collecting duct
have a number of antigenic markers including CD1, 2, and 3
(detected by monoclonal antibodies) [186—190]. gpl6O was
found on proximal tubular epithelium, gpl2O on the proximal
tubule and portions of Henle' s loop, and gp4O was present in the
distal tubule and collecting duct [191]. The monoclonal antibod-
ies can aid in isolating tubular cell populations for culture [192,
1931. Investigation of the inflammation inducing potential of the
monoclonal antibodies and/or study of their ability to selec-
tively damage segments of the nephron may uncover additional
potential nephritogenic antigens.
Exogenous antigens in the form of drugs or products of
infectious agents could be involved in "anti-cell" immune
reactions in a manner like that described in this section for
native tubular antigens. Such a mechanism would not be
dissimilar to that of a trapped antigen mechanism. The antigens
could lead to humoral or cellular immune reactions contributing
to injury of tubular cells. Viral infections of kidney cells, such
as cytomegalovirus [194], are associated with a lesion that
resembles TIN including the infiltration of T cells [195—197],
which may relate to an ongoing immune response to the
exogenous antigens present. Tubulointerstitial injury associated
with polyomavirus could be another example of a similar
mechanism [198].
Molecular mimicry and cross reactive antigens
Another consideration in the generation of autoreactive and
potentially nephritogenic antibodies is the concept of molecular
mimicry [199]. The advent of monoclonal antibodies which are
reactive with epitopes of very limited amino acid sequence has
uncovered an expanding number of epitopes with homology
between infectious agents and autoantigens that can be associ-
ated with autoimmune diseases [200]. For example, a monoclo-
nal anti-streptococcal antibody has been described which reacts
with human GBM [201]. In turn, a monoclonal anti-glomerular
antibody (reactive with a 43 kD protein) was shown to be
reactive with streptococcal M protein [2021. By using synthetic
peptides in inhibition studies renal glomerular cross reactivity
with streptococcal M protein was localized to a tetrapeptide
sequence [203]. The cross reactivity of monoclonal anti-DNA
antibodies with glomerular and extracellular matrix proteins
among other antigens is another example of this concept
[204—206]. In our experience, we have found that a portion of
monoclonal anti-viral antibodies react with sites in normal
human (or animal) tubulointerstitial tissues. The sites vary with
the particular monoclonal, suggesting that more than one
shared epitope may be present within a single virus. The
nephritogenic potential of these tubulointerstitial reactions has
not been determined.
Nephritogenic antigens involved in immune complex
accumulation
The potential nephritogenic role of numerous exogenous or
endogenous antigens in generation of immune complexes is a
consideration in TIN just as in glomerulonephritis. When gran-
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ular immunoglobulin deposits are found in the tubulointerstitial
tissues, immune complex deposits must be considered. In the
classic chronic (daily injection) serum sickness models of
immune complex glomerulonephritis in rabbits, tubulointersti-
tial immune complex deposits containing the foreign serum
protein antigen may sometimes be found [1, 2071, Interstitial
deposits are most common in rabbits with large amounts of
circulating immune complex material, and the deposits are
usually only a part of a widespread vascular deposition. In
chronic serum sickness in rats, proximal tubular dysfunction
has been noted [2081.
Since the degree of immune complex accumulation in the
extraglomerular tissues seems to relate, at least in part, to the
total amounts of immune complex material in the circulation, it
is not surprising that human diseases, such as systemic lupus
erythematosus (SLE) [13, 2091 and its experimental murine
counterparts [210] with their high levels of circulating immune
complex material, would often have striking immune deposits in
their tubulointerstjtjal tissues. In some instances of SLE, tub-
ulointerstitial disease may overshadow glomerular involvement
[2111.
As with glomerular immune complex accumulation, the
dynamics of antigen and antibody interaction must be consid-
ered. A number of factors including antigen:antibody ratio,
antibody class and affinity, antigen size, and other physico-
chemical features, as well as the clearance of complexes by the
mononuclear phagocytic system, influence the quantities and
physical characteristics of the immune complexes that reach the
kidney. Within the kidney features such as accessibility of flow
and mesangial clearance affect glomerular exposure. The sub-
sequent exposure of the peritubular vasculature is presumably
much more restricted than that of the glomerulus with its
fenestrated endothelial lining. In addition, physicochemical
features of antigen (or antibody) may play a role in selective
localization, as well as altering subsequent dynamic interchange
and reshaping of immune complex deposits by continued inter-
action of their individual components present in the circulation.
The reshaping of immune deposits may also be altered by
interactions with receptors such as those for the Fc component
of antibody or by secondary immune reactions of the rheuma-
toid factor of anti-idiotypic variety.
The number and types of antigen that could contribute to
such a mechanism in the tubulointerstitial region is potentially
large, as with immune complex glomerulonephritis; however,
the frequency with which granular deposits are encountered in
the tubulointerstitial tissue is rather low, suggesting that this
site of accumulation is infrequent except in diseases with large
levels of immune complex formation such as SLE [13, 212—2 14].
In SLE, DNA has been suggested to be present in the deposit
[2121, but as with the glomerular finding of DNA, the question
of DNA trapping with subsequent antibody reaction needs to be
considered. Cryoglobulinemia, another condition with high
levels of complexed material representing anti-idiotypic inter-
actions of immunoglobulins, may also have tubulointerstitial
deposits, as can IgA nephropathy [13, 215—217]. IgE deposits
with less striking IgG and 1gM were noted in one patient with
interstitial nephritis who had electron dense deposits as well
[218].
Table 3. Antigens in predominantly cellular nephritogenic immune
reactions
Antigens associated with delayed type hypersensitivity
Aggregated proteins, cell surface antigens, TBM antigens, ? drugs
Antigens in cellular forms of TIN
Isologous kidney homogenate, homologous renal basement
membrane preparations, heterologous TBM, presumed renal
tubular cell/TBM antigen in spontaneous TIN of kdkd mice,
?non-native materials including drugs, infectious agents, etc.
Dynamic in situ reactions including trapped or planted
antigens
The continued dynamic interchange of antigen and antibody
in immune complex accumulation was discussed above. The
questions raised regarding the direct tissue binding of DNA in
SLE suggest that the granular, presumed immune complex,
deposits found in the tubulointerstitial tissues might also have
originated by direct antibody interaction with previously
trapped antigen or cellular antigens. Such a mechanism has
been demonstrated clearly in glomeruli in the autologous phase
of experimental anti-GBM antibody disease and in lectin and
cationic protein binding models [1]. As noted above, anti-
idiotypic antibodies or rheumatoid factors can react with pre-
viously deposited immunoglobulins. Drug-related antigens have
occasionally been identified in drug-associated forms of TIN,
serving either as haptens, trapped antigens, or both; however,
actual examples are scarce [2191.
Antigens in predominantly cellular nephritogenic immune
reactions
Antigens in delayed-type hypersensitivity reactions
Aggregated, but not soluble, proteins such as bovine gamma
globulin placed in the renal tubulointerstitial tissue of a previ-
ously sensitized recipient will cause a delayed-type hypersen-
sitivity reaction [220] (Table 3). The lesion can be transferred
with immune cells, but not serum, and the aggregation of the
antigen seems to be important in delaying its diffusion away
from the site. Other antigens that have been used successfully
for this type of reaction include purified protein derivative and
dodecanoic acid conjugated to bovine serum albumin [221].
Lesions induced by intrarenal injection of Tamm-Horsfall pro-
tein or egg white component into sensitized hosts are also noted
to induce areas of TIN; however, the exact mechanism of injury
has not been worked out [2221. TIN associated with therapeutic
drug administration could have a similar component, although
model systems have not been fully explored and assessment of
delayed type hypersensitivity is not a common practice in
evaluation of such lesions in humans. It remains to be seen if
interstitial cellular infiltrates containing cytotoxic T cells and
macrophages such as those associated with severe induced
glomerular proteinuria (aminonucleoside or adriamycin toxic-
ity) have a cellular immune basis [223, 2241.
Antigens in cellular forms of TiN
The TBM antigen systems associated with the formation of
anti-TBM antibodies can also be involved in cellular immune
responses. As noted earlier, anti-TBM antibodies do not appear
to be major contributors to the slowly developing TIN of the
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SJL mouse induced by immunization with heterologous TBM
antigens. Instead, there is considerable evidence to support a
predominant cellular immune mediation for the lesion. The
susceptible SJL mice develop a MHC class I restricted, Lyt-2
effector cell which can adoptively transfer the TIN [225—228].
The Lyt-2 effector cell expresses idiotypes shared with kid-
ney-bound anti-TBM antibodies, suggesting the similarity in
reactive antigens [229]. Nonsusceptible mouse strains develop
L3T4 class II restricted effector T cells but do not develop
interstitial lesion [225]. The non susceptibility appears to relate
to modulation of the phenotypic selection of effector cells via
the immunoregulatory balance afforded by suppression and
countersuppression with the involvement of soluble suppressor
factors [227, 228, 230, 2311.
The proximal tubular epithelial cell line producing the 3M- 1
antigen also expresses MHC class II antigens and can support
the proliferation of MHC class II restricted helper T cell lines in
culture [34]. Antibodies reactive with the 3M-i antigen can
down regulate in vitro MHC class II expression on proximal
tubular epithelial cell lines synthesizing 3M-l [232]. The class II
augmenting effect of recombinant interferon gamma on renal
tubular cell class II expression in vivo is also diminished by anti
3M-i antibody [232]. Proximal renal tubular enhancement of
MHC class II expression is also a feature of the autoimmune
disease of the MRL/lpr lupus mice [233]. The possible role of
other tubular cell surface components, such as the adhesion
molecules LFA-3 and ICAM- I capable of interaction with
lymphocyte adhesion molecules, is also under study [234].
As in the case of the SJL mouse TIN noted above, TBM
antigens can also serve as immunogens to induce cellular
immune responses capable of causing TIN apparently indepen-
dently of the associated anti-TBM antibody response in the
LEW rat. LEW rats, which lack an accessible nephritogenic
TBM antigen present in the BN rat, can be induced to develop
TIN after immunization with BN renal basement antigen. When
the LEW rat is given the BN antigen, it develops a granuloma-
tous form of TIN in association with circulating, but not renal,
fixed anti-TBM antibodies, except in very occasional segments
of TBM apparently altered by the inflammatory reaction to
expose normally sequestered antigens [46]. Phenotypic charac-
terization of the infiltrating cells reveals 50 to 60% helper T
cells, ito 5% cytotoxic T cells, and almost all of the infiltrating
cells positive for rat Ia. Specifically-sensitized lymph node cells
from the immunized LEW rat can passively transfer the gran-
ulomatous TIN to naive LEW rats.
The histologic features of the LEW lesion are very different
from the anti-TBM antibody-associated TIN of the BN rat
described in an earlier section and raise the question regarding
involvement of different antigens. The granulomatous TIN in
the LEW can be induced with the TBM from any rat strain that
has TBM antigens detected with LEW or BN anti-TBM anti-
body, and heterologous TBM containing similar antigens will
induces less severe forms of the lesion.
The histologic and phenotypic characteristics of the inflam-
matory infiltrate in the LEW model of granulomatous nephritis
described here may provide some insight into the mechanisms
responsible for similar histologic forms of TIN in humans
associated with drugs and other conditions [235—2391.
In addition to the prominent disease-associated anti-TBM
antibody response, the BN rat immunized with heterologous
TBM develops immune cells sensitized to the immunogen, and
these cells can transfer a mild local lesion after transfer under
the renal capsule [240, 2411. The infiltrating cells from the renal
interstitium are sensitized to the immunogen, bovine TBM, and
to purified protein derivative from the complete Freund's
adjuvant but not to a number of autologous TBM and renal
antigens in a test system used which might not have eliminated
an effect of suppressor cells possibly present in the mixed cell
population in the infiltrate [241].
Even the guinea pig model of anti-TBM antibody TIN, which
as noted above is easily transferable by antibody, has added
evidence of a component of cellular immunity. Cellular reactiv-
ity to chaotrope-solubilized fractions of the immunogen is found
in lymphocytes from the immunized guinea pigs, and sensitized
cells can migrate in a selective fashion to the kidney of
unimmunized guinea pigs [242, 243]. In addition, such cells are
cytotoxic to monolayers of cells derived from guinea pig
kidney. Factors, presumably cytokines such as interleukin-i,
from the stimulated immune cell population, induce fibroblast
proliferation and collagen synthesis [244]. A macrophage
chemoattractant has been noted in the renal venous blood and
relates temporally with macrophage influx [245].
The TIN of the kdkd mouse, a congenic subline of the
CBA/Ca strain, appears to be cell mediated [246—248]. The
disease can be transferred with kdkd cells to produce CBA/Ca
bone marrow chimeras. The antigen may reside in the TBM
since a delayed-type hypersensitivity reaction to collagenase
solubilized CBA/Ca TBM occurs in CBA/Ca mice treated with
cyclophosphamide to eliminate T cells capable of suppressing
disease development [249, 250]. Disease transfer is possible
using kdkd cells in CBA/Ca treated mice to eliminate suppres-
sor cells or by placing the cells under the renal capsule of
cyclophosphamide treated CBA/Ca mice. The disease onset in
the kdkd relates to the functional inactivation of suppressor T
cells present early in life by antigen-specific countersuppressor
T cells [250]. It is suggested that the human condition termed
medullary cystic disease-familial juvenile nephronophthisis
complex is a parallel of the kdkd disease [251].
Renal tubular antigens and renal tubular functional disorders
A number of conditions associated typically with hypergam-
maglobulinemia (and a variety of autoantibodies), including
SjOgren's syndrome, can be complicated by TIN and renal
functional changes, often presenting as distal renal tubular
acidosis (RTA) and, less frequently, hypokalemia and/or uri-
nary concentrating defects [252—260]. Another association with
hypergammaglobulinemia has been TIN often in adolescent
girls with uveitis, circulating immune complexes, granulomas in
bone marrow, and absence of renal immune deposits [261—265].
Morphologically, the TIN in Sjogren's syndrome and other
hypergammaglobul inemic RTA-associated conditions is charac-
terized by a mononuclear cell infiltrate [266—270] which has a
predominantly T helper cell phenotype (CD4), sometimes with
nodules of B cells, and lesser numbers of monocytes and
infrequent NK cells [271, 2721. In one study the lymphocytes
that invaded the tubular epithelial cells were noted to be CD8
and CD16, suggesting their role as cytotoxic T cells [273].
Few studies are available to determine cellular reactivity to
tubular antigens in patients with Sjogren's syndrome or renal
tubular acidosis. In one such study, an increased frequency of
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cell-mediated immune response, as monitored by leukocyte
migration to urinary Tamm-Florsfall protein, was noted in
patients with liver disease and renal tubular acidosis when
compared with those with liver disease alone [2741. In addition,
lymphocytes from 10 of 13 patients with chronic active hepatitis
or primary biliary cirrhosis and associated renal tubular acido-
sis were shown to be cytotoxic for a kidney cell line known to
secrete Tamm-Horsfall glycoprotein [275].
The tubular defects have been associated with immune de-
posits (Ig and/or C) in and around the renal tubules in a portion
of the relatively few patients studied. Granular IgG deposits
were found in the cytoplasm of tubular epithelial cells in two of
three biopsies from patients with Sjogren's syndrome who had
impaired urinary acidification [276]. Ig deposits were seen in
tubules and in areas of interstitial infiltrate in four patients with
renal tubular acidosis, who also had circulating antibodies
reactive with a variety of tissue antigens, including renal tubular
antigens [2771, and Ig deposits were present in a granular
pattern in tubular epithelial cells in another patient with RTA
[278]. IgG and C3, but not tubular antigen, deposits were found
in an irregular granular pattern along some of the TBMs, with
electron dense deposits in a patient with TIN associated with
Sjogren's syndrome [279]. Ig deposits were observed in the
renal interstitium of a patient with TIN and Sjogren's syndrome
in the absence of detected anti-renal antibodies [280], and a
number of other studies have shown Ig and C3 deposits in
some, but clearly not all, patients with Sjogren's syndrome or
RTA studied [272, 273, 281—284].
The finding of Ig deposits in some renal biopsies of patients
with diseases associated with RTA, along with the presence of
numerous autoantibodies in the serum of these patients, sug-
gests a possible humoral immune mechanism. In one patient,
neonatal renal tubular dysfunction was thought to be induced
by transplacental passage of IgG from a mother with Sjogren's
syndrome [285]. The serum antibodies were reactive with
antigens present in distal renal tubular cells. An enzyme immu-
noassay for anti-Tamm-Horsfall protein antibodies was positive
in both the infant's and the mother's sera. Improved renal
tubular function accompanied the disappearance of the antibod-
ies from the infant's circulation. Antibodies reactive with the
loop of Henle have been noted in a patient with renal tubular
acidosis but are not confined to the condition [286]. In another
patient, antibodies reactive with components of the renal tubu-
lar plasma membrane and capable of blocking PTH-induced
phosphaturia were found in a patient with pseudohypoparathy-
roidism Type II and Sjogren's syndrome [287]. Antibodies
reactive with cells of the renal collecting ducts have been
reported associated with antibodies to thyroid, gastric parietal
cells, and intrinsic factor in patients with thyroid disorders and
pernicious anemia; one patient had associated RTA, and three
other patients with RTA had anti-collecting duct antibodies
[288).
The immunopathogenic contributions of the T cell-rich inter-
stitial infiltrates, immune deposits, and anti-tubular cell anti-
bodies remain unclear. To be important in the generation of a
lesion, a specific tubular antigen(s) would be expected to be the
target of the immune attack leading to a site directed inflamma-
tory response. Since distal renal tubular acidosis is one of the
most common abnormalities present, portions of the distal
nephron responsible for acidification would be suspect sites for
the antigen(s) to which an autoimmune response is directed.
Additional tubular abnormalities could occur nonspecifically
related to the extent of the associated inflammatory response.
Unfortunately, models of Sjogren's syndrome employ either the
autoimmune mice strains with their background of lupus nephri-
tis or spontaneous or induced lesions without reported renal
study, which to date have not been helpful in advancing our
knowledge of the immune factors responsible for the observed
renal tubular dysfunction [289—293].
Conclusions
In TIN, an increasing number of antigens with nephritogenic
potential have been defined, with variable investigational sup-
port, as candidates to parallel many of the types of immuno-
pathogenic mechanisms studied in more detail in glomerulone-
phritis. The nature and distribution (extracellular matrix, cell
surface, etc.) of the antigens (native or non-native) determine
the type and location of the tubulointerstitial immune injury. In
contrast to glomerular antigens, the nephritogenic antigens in
TIN are often relatively sequestered from the circulation,
thereby limiting their direct access by components of the
immune system and, in turn, perhaps modifying their phlogo-
genic potential. The immunopathogenic mechanisms involve
both the humoral and cellular limbs of the immune response to
different degrees. Complex antigens, such as the TBM, can be
associated with situations in which either antibody or cellular
immune mechanisms predominate in producing injury in some
species (or strains), with evidence for temporal variation in the
contribution of either mechanism. In addition to the TBM-
associated antigens, many other renal tubular compojlents
including the proximal tubular brush border and Tamm-Horsfall
protein as well as non-native soluble and trapped antigens, have
at least partial, if not complete, experimental support in spon-
taneous or induced nephritogenic immune reactions in the
tubulointerstitial tissues. Renal tubular cell antigens have also
been linked by limited evidence to renal tubular dysfunction
associated with autoimmune diseases such as Sjogren's syn-
drome. Considerably more work is needed to refine and expand
the current experimental and limited clinical evidence to fully
understand the contributions of the various mechanisms in the
immunopathogenesis of human TIN, where it is often difficult to
acquire the appropriate materials for in-depth immunopatho-
logic study.
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